ヘルスケア開発業務受託機関市場：タイプ、サービス、治療分野、エンドユーザー別-2025-2030年世界予測

ヘルスケア開発業務受託機関市場の2024年の市場規模は600億3,000万米ドルで、2025年にはCAGR 10.57%で662億5,000万米ドルに成長し、2030年には1,097億2,000万米ドルに達すると予測されています。

進化するヘルスケアCROランドスケープの包括的導入

近年、テクノロジーの急速な進歩、規制環境の変化、市場のダイナミックな需要に牽引され、ヘルスケア開発業務受託領域は大きな進化を遂げています。本セクションでは、効率性、正確性、研究機関と医薬品イノベーター間の戦略的協業が重視されるようになったことを特徴とする現在の状況を概観し、その舞台を整えます。かつては伝統的な調査方法が主流であった市場は、デジタルトランスフォーメーション、革新的なデータ分析、バイオテクノロジーの新興動向を受け入れ、医薬品開発と臨床研究のアプローチを再定義しています。学術研究機関、製薬会社、バイオテクノロジー企業は、これまで以上に柔軟で費用対効果が高く、統合された研究ソリューションを求めています。利害関係者がこのような変化に適応していく中で、戦略的パートナーシップと卓越したオペレーションの追求は必要不可欠なものとなっています。このイントロダクションは、技術的・手法的なブレークスルーを活用しつつ、厳格な科学的基準を維持することの重要性を強調し、不確実性と急速な変化を特徴とする環境において、研究活動が倫理的かつ経済的に実行可能であり続けることを保証するものです。

実用的な洞察と先見的な戦略に重点を置いた本調査は、臨床研究の未来を形作る多面的な課題と機会を掘り下げ、最終的には意思決定者と業界専門家双方にとって不可欠なリソースを提供します。

ヘルスケア開発業務受託の状況を再定義する変革的変化

ヘルスケア開発業務受託セクターは、技術革新と規制の枠組みの再編成に支えられた変革期を迎えています。高度な自動化、リアルタイムのデータ分析、人工知能システムが従来の研究パラダイムを再構築し、企業はより効率的で正確な臨床研究を実施できるようになりました。患者中心のデザインと適応型臨床試験が重視されるようになったことで、研究の管理方法が強化され、その結果、市場投入までの時間が短縮され、資源配分が最適化されるようになりました。さらに、規制当局の義務付けが進化したことで、企業はより機敏なコンプライアンス戦略を採用するようになり、研究プロトコールが世界スタンダードに沿ったものとなり、同時に地域特有の要件にも対応できるようになりました。

このような革新的なシフトは、デジタルソリューションとバイオ医薬品の専門知識をうまく統合することが重要となる競合環境を促進しました。デジタルインフラストラクチャ、クラウドベースのデータエコシステム、相互運用可能なテクノロジーへの投資は、現在、関連性を維持するための中心となっています。組織はビジネスモデルを見直し、硬直的な運営方法から、より柔軟で革新的な枠組みへと移行し、今日の研究需要によりよく対応しています。業界のリーダーたちは、このようなダイナミックな変化を受け入れることで、協力体制の強化、研究成果の向上、ひいては救命治療薬をより早く市場に送り出すための基盤が構築されることを認識しています。テクノロジーと規制改革の融合は、業務プロセスを合理化するだけでなく、画期的な研究アプローチへの道をさらに開いています。

市場戦略を形成する複雑なセグメンテーションの洞察

市場セグメンテーションを詳細に調査することで、戦略的な意思決定に不可欠なヘルスケア受託研究業界の高度な構造が明らかになります。包括的なリサーチソリューションを提供するフルサービス企業と、ターゲットとするサービス分野に特化した機能的サービスプロバイダーを区別し、サービスプロバイダーのタイプ別に市場を調査しています。この区別は、提供されるサービスの種類に基づくセグメンテーションによって補完され、その範囲は、強固な臨床試験の実施や戦略的コンサルティングから創薬や薬事まで多岐にわたる。臨床試験のフェーズは、第I相、第II相、第III相、第IV相の各試験に細かく分けられ、臨床開発プロセスの各段階における専門性の深さが強調されています。

治療領域別の分析では、心血管疾患、内分泌関連疾患、免疫疾患、感染症、代謝性疾患、神経疾患、腫瘍など、多様な健康状態に関する調査が行われています。最後に、エンドユーザーセグメンテーションから得られた洞察は、学術研究機関、バイオテクノロジー企業、政府機関、医療機器メーカー、製薬会社などの利害関係者の多様なニーズを示しています。これらのセグメンテーションの枠組みは、現在のサービス提供モデルを概説するだけでなく、新たな市場機会に参入するために不可欠な、的を絞ったイノベーションと戦略的パートナーシップを促進します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品および医療機器の開発の増加
    • 世界の慢性疾患の増加と人口の高齢化
    • 製薬業界とバイオテクノロジー業界の研究開発費の増加
  • 抑制要因
    • 調査プロセスと品質問題に対する制御が限られている
  • 機会
    • AIとMLの統合によるデータ処理と試験管理の強化
    • バイオテクノロジーと個別化医療の進歩
  • 課題
    • 複雑な規制枠組みとコンプライアンスの課題を乗り越える
• 市場セグメンテーション分析
  • タイプ：統合されたエンドツーエンドのソリューションを提供するフルサービス組織への嗜好が増加
  • エンドユーザー：医療機器メーカーにおけるヘルスケアCROの重要性の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 ヘルスケア開発業務受託機関市場：タイプ別

• フルサービス組織
• 機能サービスプロバイダー

第7章 ヘルスケア開発業務受託機関市場：サービス別

• 臨床試験
  • フェーズI試験
  • フェーズII試験
  • フェーズIII試験
  • フェーズIV試験
• コンサルティングおよびアドバイザリーサービス
• 創薬
• 規制関連業務

第8章 ヘルスケア開発業務受託機関市場治療領域別

• 心血管疾患
• 内分泌学
• 免疫学
• 感染症
• 代謝障害
• 神経学
• 腫瘍学

第9章 ヘルスケア開発業務受託機関市場：エンドユーザー別

• 学術調査機関
• バイオテクノロジー企業
• 政府機関
• 医療機器メーカー
• 製薬会社

第10章 南北アメリカのヘルスケア開発業務受託機関市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のヘルスケア開発業務受託機関市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのヘルスケア開発業務受託機関市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advanced Clinical LLC
• Alcanza Clinical Research, LLC.
• Almac Group LIMITED
• CELERION, INC.
• Charles River Laboratories, Inc.
• Clario, Inc.
• Ergomed Plc
• Eurofins Scientific SE
• ICON plc
• IQVIA Inc.
• Laboratory Corporation
• Medpace, Inc.
• Parexel International Corporation
• Pharmaron Beijing Co., Ltd.
• PPD LLC by Thermo Fisher Scientific Inc.
• PSI CRO AG
• SGS SA
• SGS Societe Generale de Surveillance SA
• SIGNANT HEALTH LIMITED
• Syneos Health Inc.
• Syngene International Limited
• TFS International AB
• Worldwide Clinical Trials Holdings, Inc.
• WuXi AppTec Co., Ltd.

LIST OF FIGURES

• FIGURE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET MULTI-CURRENCY
• FIGURE 2. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET MULTI-LANGUAGE
• FIGURE 3. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET RESEARCH PROCESS
• FIGURE 4. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET DYNAMICS
• TABLE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY FULL-SERVICE ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY FUNCTIONAL SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE I TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE II TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE III TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE IV TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CONSULTING & ADVISORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 52. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 53. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 54. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 79. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 80. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 81. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 84. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 85. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 86. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 170. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 171. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 172. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 190. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 191. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 192. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 195. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 196. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 197. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 243. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 244. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2024

The Healthcare Contract Research Organization Market was valued at USD 60.03 billion in 2024 and is projected to grow to USD 66.25 billion in 2025, with a CAGR of 10.57%, reaching USD 109.72 billion by 2030.

Comprehensive Introduction to the Evolving Healthcare CRO Landscape

In recent years, the healthcare contract research domain has experienced significant evolution driven by rapid advancements in technology, shifting regulatory environments, and dynamic market demands. This section sets the stage by presenting an overview of the current landscape, characterized by increased emphasis on efficiency, accuracy, and strategic collaboration between research organizations and pharmaceutical innovators. The market, once dominated by traditional research processes, has embraced digital transformation, innovative data analytics, and emerging biotechnology trends, which in turn have redefined approaches to drug development and clinical research. Academic research institutes, pharmaceutical companies, and biotechnology firms are seeking more flexible, cost-effective, and integrated research solutions than ever before. As stakeholders adapt to these changes, strategic partnerships and the pursuit of operational excellence have become essential imperatives. This introduction underscores the importance of maintaining rigorous scientific standards while capitalizing on technological and methodological breakthroughs, thereby ensuring that research activities remain both ethical and financially viable in an environment marked by uncertainty and rapid change.

With an emphasis on actionable insights and forward-thinking strategies, this exploration delves into the multifaceted challenges and opportunities shaping the future of clinical research, ultimately providing an indispensable resource for decision-makers and industry experts alike.

Transformative Shifts Redefining the Healthcare Contract Research Landscape

The healthcare contract research sector is undergoing transformative shifts underpinned by both technological innovation and a realignment of regulatory frameworks. Advanced automation, real-time data analytics, and artificial intelligence systems have restructured traditional research paradigms, enabling organizations to conduct more efficient and accurate clinical studies. Increased emphasis on patient-centric designs and adaptive clinical trials has enhanced the way research is managed, thereby reducing time to market and optimizing resource allocation. Moreover, evolving regulatory mandates have prompted organizations to adopt more agile compliance strategies, ensuring that research protocols align with global standards while accommodating localized requirements.

These innovative shifts have fostered a competitive environment where well-orchestrated integrations between digital solutions and biopharmaceutical expertise are critical. Investments in digital infrastructure, cloud-based data ecosystems, and interoperable technologies are now central to staying relevant. Organizations are rethinking their business models, transitioning from rigid operational methods to more flexible and innovative frameworks that better meet today's research demands. Leaders within the industry are recognizing that embracing these dynamic changes creates a platform for enhanced collaboration, improved study outcomes, and ultimately, faster delivery of life-saving therapies to the market. The convergence of technology and regulatory reform is not only streamlining operational processes but also opening further avenues for groundbreaking research approaches.

Intricate Segmentation Insights Shaping Market Strategies

A detailed examination of market segmentation reveals a sophisticated structure within the healthcare contract research industry that is critical for strategic decision-making. The market is explored according to the type of service provider, differentiating between full-service organizations that offer comprehensive research solutions and functional service providers specialized in targeted service areas. This distinction is complemented by a segmentation based on the types of services provided, ranging from robust clinical trial execution and strategic consulting to drug discovery and regulatory affairs. Within clinical trials, the phases are meticulously divided into Phase I, Phase II, Phase III, and Phase IV trials, highlighting the depth of specialization at each stage of the clinical development process.

Further granularity is found in the analysis based on therapeutic areas, where research spans a diverse array of health conditions including cardiovascular diseases, endocrinology-related conditions, immunological disorders, infectious diseases, metabolic disorders, neurological conditions, and oncology. Last, insights drawn from end-user segmentation illustrate the varied needs of stakeholders such as academic and research institutes, biotechnology companies, government organizations, medical device manufacturers, and pharmaceutical companies. These segmentation frameworks not only outline current service delivery models but also facilitate targeted innovations and strategic partnerships that are indispensable for penetrating emerging market opportunities.

Based on Type, market is studied across Full-Service Organizations and Functional Service Providers.

Based on Services, market is studied across Clinical Trials, Consulting & Advisory Services, Drug Discovery, and Regulatory Affairs. The Clinical Trials is further studied across Phase I Trials, Phase II Trials, Phase III Trials, and Phase IV Trials.

Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Endocrinology, Immunology, Infectious Diseases, Metabolic Disorders, Neurology, and Oncology.

Based on End-User, market is studied across Academic & Research Institutes, Biotechnology Companies, Government Organizations, Medical Device Manufacturers, and Pharmaceutical Companies.

Regional Insights Highlighting Global Market Dynamics

Regional analysis provides a clear perspective on how geographical nuances influence market trends and operational strategies within the healthcare contract research sector. In the Americas, a robust ecosystem characterized by substantial investments in research and development, coupled with advanced healthcare infrastructure, positions the region as a hub for innovative clinical research practices. Transitioning towards Europe, the Middle East, and Africa, distinct regulatory environments and diversely structured healthcare systems create a landscape where tailored research solutions are paramount for ensuring compliance and efficacy in clinical operations. Meanwhile, the Asia-Pacific region stands out with rapidly emerging markets, increasing government support for technological advancements, and a vast pool of clinical research talent, offering new opportunities for expansive growth.

These regional insights illustrate that while each geographic area faces unique challenges, there is a shared drive towards enhancing patient outcomes and accelerating the drug development process. By aligning localized strategies with overarching global trends, organizations are better positioned to navigate complex market dynamics and address both the immediate needs and future demands of the healthcare industry. This regional perspective emphasizes the importance of understanding geopolitical influences, economic conditions, and cultural trends that collectively shape the clinical research landscape on a global scale.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insightful Analysis of Leading Companies Steering the Market

A close examination of the competitive landscape reveals a constellation of companies that are significantly influencing the direction of the contract research market. Industry leaders such as Advanced Clinical LLC, Alcanza Clinical Research, LLC., and Almac Group LIMITED have established strong reputations for innovation and operational excellence. The influence of other key players including CELERION, Charles River Laboratories, Inc., and Clario, Inc. is equally noteworthy as they continually enhance research capabilities through cutting-edge technologies and robust service portfolios. Renowned establishments such as Ergomed Plc, Eurofins Scientific SE, and ICON plc contribute to market developments through strategic investments in clinical research infrastructure.

The competitive arena is further characterized by substantial contributions from leading global entities like IQVIA Inc., Laboratory Corporation, and Medpace, Inc., which have harnessed vast resources to streamline clinical trial operations. Organizations such as Parexel International Corporation, Pharmaron Beijing Co., Ltd., and PPD LLC by Thermo Fisher Scientific Inc. demonstrate the power of strategic partnerships and the integration of diversified service offerings. Additional influential companies including PSI CRO AG, SGS SA, SGS Societe Generale de Surveillance SA, SIGNANT HEALTH LIMITED, Syneos Health Inc., Syngene International Limited, TFS International AB, Worldwide Clinical Trials Holdings, Inc., and WuXi AppTec Co., Ltd. round out the competitive landscape. This comprehensive blend of innovation, market expertise, and strategic collaborations among leading companies is instrumental in driving the future course of clinical research and reinforcing industry standards.

The report delves into recent significant developments in the Healthcare Contract Research Organization Market, highlighting leading vendors and their innovative profiles. These include Advanced Clinical LLC, Alcanza Clinical Research, LLC., Almac Group LIMITED, CELERION, INC., Charles River Laboratories, Inc., Clario, Inc., Ergomed Plc, Eurofins Scientific SE, ICON plc, IQVIA Inc., Laboratory Corporation, Medpace, Inc., Parexel International Corporation, Pharmaron Beijing Co., Ltd., PPD LLC by Thermo Fisher Scientific Inc., PSI CRO AG, SGS SA, SGS Societe Generale de Surveillance SA, SIGNANT HEALTH LIMITED, Syneos Health Inc., Syngene International Limited, TFS International AB, Worldwide Clinical Trials Holdings, Inc., and WuXi AppTec Co., Ltd.. Actionable Recommendations for Strategic Industry Leadership

Success in a rapidly evolving clinical research landscape requires a proactive and multifaceted approach, underpinned by a commitment to innovation and operational resilience. Industry executives are advised to invest in integrated digital solutions that enhance data management, streamline compliance procedures, and foster seamless collaboration across different stages of research. Prioritizing adaptive clinical trial designs is essential, as these models allow organizations to react quickly to emerging data and evolving patient needs.

Moreover, industry leaders should focus on bolstering partnerships with technology innovators and academic institutions to gain early access to breakthrough methodologies. Enhancing transparency and communication across departments not only improves process efficiency but also strengthens stakeholder trust. A rigorous emphasis on training and development should be maintained, ensuring that teams are well-equipped with the latest tools and regulatory knowledge. Additionally, proactive market intelligence systems should be established to track emerging trends and gauge competitive moves in real time. By prioritizing these strategies, decision-makers can effectively navigate regulatory uncertainties, optimize resource allocation, and better anticipate market shifts, ensuring that their organizations remain at the forefront of clinical research innovation.

Conclusion Summarizing Strategic Market Insights

The analysis elucidates a vibrant and dynamically evolving landscape in the healthcare contract research sector, where transformative technological advancements, innovative service models, and nuanced market segmentation intersect to drive industry growth. By dissecting the market along dimensions such as provider types, service offerings, therapeutic areas, and end-user demands, the discussion provides a detailed understanding of the multifaceted factors influencing clinical research today. Regional nuances and competitive intelligence further underscore the need for agile strategies that respond both to global trends and localized market dynamics.

This comprehensive exploration not only highlights the imperative of embracing digital transformation and adaptive trial designs but also reinforces the significance of strategic partnerships. The evolving regulatory environment and increasing demand for patient-centric research models are reshaping competitive dynamics and creating opportunities for innovation. Ultimately, the insights presented here serve as a robust foundation for stakeholders seeking to optimize operational efficiency and achieve sustainable market growth through informed, strategic decision-making that is responsive to continuous industry shifts.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of drug and medical device developments
    • 5.1.1.2. Rising prevalence of chronic diseases and an aging population globally
    • 5.1.1.3. Growing R&D expenditures by pharmaceutical and biotech industries
  • 5.1.2. Restraints
    • 5.1.2.1. Limited control over the research process & quality issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of AI and ML to enhance data processing and trial management
    • 5.1.3.2. Advancements in biotechnology and personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Navigating complex regulatory frameworks and compliance challenges
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing preference for full-service organizations for providing integrated and end-to-end solutions
  • 5.2.2. End-User: Rising significance of healthcare CROs among medical device manufacturers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Healthcare Contract Research Organization Market, by Type

• 6.1. Introduction
• 6.2. Full-Service Organizations
• 6.3. Functional Service Providers

7. Healthcare Contract Research Organization Market, by Services

• 7.1. Introduction
• 7.2. Clinical Trials
  • 7.2.1. Phase I Trials
  • 7.2.2. Phase II Trials
  • 7.2.3. Phase III Trials
  • 7.2.4. Phase IV Trials
• 7.3. Consulting & Advisory Services
• 7.4. Drug Discovery
• 7.5. Regulatory Affairs

8. Healthcare Contract Research Organization Market, by Therapeutic Area

• 8.1. Introduction
• 8.2. Cardiovascular Diseases
• 8.3. Endocrinology
• 8.4. Immunology
• 8.5. Infectious Diseases
• 8.6. Metabolic Disorders
• 8.7. Neurology
• 8.8. Oncology

9. Healthcare Contract Research Organization Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Biotechnology Companies
• 9.4. Government Organizations
• 9.5. Medical Device Manufacturers
• 9.6. Pharmaceutical Companies

10. Americas Healthcare Contract Research Organization Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Healthcare Contract Research Organization Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Healthcare Contract Research Organization Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. NAMSA and Terumo forge strategic partnership to accelerate global medical device development
  • 13.3.2. BioPharma Services expands its capabilities into a full-service CRO with late-stage trials & AI integration
  • 13.3.3. Lindus Health launches an all-in-one consumer health CRO with advanced eClinical technology
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Clinical LLC
• 2. Alcanza Clinical Research, LLC.
• 3. Almac Group LIMITED
• 4. CELERION, INC.
• 5. Charles River Laboratories, Inc.
• 6. Clario, Inc.
• 7. Ergomed Plc
• 8. Eurofins Scientific SE
• 9. ICON plc
• 10. IQVIA Inc.
• 11. Laboratory Corporation
• 12. Medpace, Inc.
• 13. Parexel International Corporation
• 14. Pharmaron Beijing Co., Ltd.
• 15. PPD LLC by Thermo Fisher Scientific Inc.
• 16. PSI CRO AG
• 17. SGS SA
• 18. SGS Societe Generale de Surveillance SA
• 19. SIGNANT HEALTH LIMITED
• 20. Syneos Health Inc.
• 21. Syngene International Limited
• 22. TFS International AB
• 23. Worldwide Clinical Trials Holdings, Inc.
• 24. WuXi AppTec Co., Ltd.